Literature DB >> 7034525

Steroid diabetes in childhood.

K Perlman, R M Ehrlich.   

Abstract

Hyperglycemia and glycosuria are known to occur in some children receiving corticosteroids. In a retrospective study 24 such episodes were identified in 17 patients receiving steroids for a variety of primary diseases from 1968 to 1979. Detection based on symptoms averaged 26 days from initiation of steroid treatment, whereas detection based on the presence of glycosuria or hyperglycemia averaged 4.5 days. Acidosis, ketosis, and hyperglycemia (glucose level, greater than 500 mg/dL) occurred in 2, 4, and 8 patients, respectively. Insulin therapy was necessary in 15 episodes in 11 patients, but in three episodes the insulin dosage was reduced while the steroid dosage remained high. Permanent insulin dependence developed immediately in one patient and eventually in three others. Steroid-precipitated diabetes must be anticipated but should not interfere with the treatment of the primary disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7034525     DOI: 10.1001/archpedi.1982.03970370066017

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  4 in total

1.  Clinical Considerations Regarding the Use of Thiopurines in Older Patients with Inflammatory Bowel Disease.

Authors:  Margalida Calafat; Míriam Mañosa; Fiorella Cañete; Eugeni Domènech
Journal:  Drugs Aging       Date:  2021-01-13       Impact factor: 3.923

2.  Non-ketotic hyperosmolar coma complicating steroid treatment in childhood nephrosis.

Authors:  J Y Yang; X L Cui; X J He
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

3.  Prediction of type 1 diabetes mellitus--a report on three cases.

Authors:  G J Bruining; J L Molenaar; B M de Jongh; R S Aarsen; H K Visser
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

Review 4.  The role of environmental factors in insulin-dependent diabetes mellitus: an unresolved issue.

Authors:  M R Kraine; R M Tisch
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.